Complement-Based Drug Development Summit leaderboard
  • Tuesday, August 25, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 253

Author

Pharma Journalist 9017 posts 0 comments

advanco and Vantage Partner to Offer First Interoperable Pharma Traceability Solution

Sep 7, 2022
Advanco SA announced that it is partnering with Vantage Solutions to provide the first open, interoperable, and secure traceability solution for the Pharmaceutical Industry. advanco is…
Read More...

Evaxion Announces NIH Grant for Research Collaboration With UMass Chan Medical School

Sep 7, 2022
Evaxion Biotech A/S announced that the Company, in collaboration with UMass Chan Medical School, has received a grant from the U.S. National Institutes of Health (“NIH”) for the…
Read More...

ixlayer Partners with Curavit to Enable Convenient Patient Medical Testing Services for…

Sep 7, 2022
Curavit Clinical Research, a virtual contract research organization (VCRO), has entered into a long-term partnership with ixlayer to provide easy access to clinical-grade diagnostic lab…
Read More...

NaNotics to Collaborate with Mass General Cancer Center (MGCC) on Novel Nanomedicine for Treating…

Sep 7, 2022
NaNotics LLC, a biopharmaceutical company developing NaNots, novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood, announced a…
Read More...

Kite’s CAR T-cell Therapy Tecartus Granted European Marketing Authorization for the Treatment of…

Sep 7, 2022
Kite, a Gilead Company announced that the European Commission (EC) has approved its CAR T-cell therapy Tecartus (brexucabtagene autoleucel) for the treatment of adult patients 26 years…
Read More...

Bertis Announces Proteomic Based Research Results of New Biomarker for Ovarian Cancer Diagnosis

Sep 6, 2022
Bertis, a proteomics-based precision medicine technology development company (CEOs Dong-young Noh, Seung-man Han), announced on the 5th that the research results of their search for…
Read More...

InnoCare Announces Priority Review of Orelabrutinib for the Treatment of R/R MZL by NMPA

Sep 6, 2022
InnoCare Pharma announced that BTK inhibitor orelabrutinib has been granted priority review for the treatment of relapsed or refractory Marginal Zone Lymphoma (R/R MZL) by the Center…
Read More...

Forxiga approved in China for the treatment of chronic kidney disease in patients at risk of…

Sep 6, 2022
AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in China to reduce the risk of sustained estimated glomerular filtration…
Read More...

CARsgen Releases the First Clinical Batch of CAR T Cells from its RTP GMP Manufacturing Facility in…

Sep 6, 2022
CARsgen Therapeutics Holdings Limited announces that the company’s Current Good Manufacturing Practice (CGMP) manufacturing facility located at the Research Triangle Park (RTP) in North…
Read More...

AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF KONVOMEP (omeprazole and sodium bicarbonate…

Sep 6, 2022
Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose-forms and formulations of products to serve the needs of overlooked patients, announced that the…
Read More...
Prev Next
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Piramal Pharma Takes Majority Stake in Yapan Bio
  • Charles River and Medigen Partner on Next-Generation Enterovirus Vaccine
  • WellSpan and Johns Hopkins Expand Cancer Care Collaboration
  • SandboxAQ Launches AI Model to Speed Drug Discovery
  • FDA Approves Ultragenyx Gene Therapy for Rare GSDIa Disorder

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.